Anti-Sm antibodies are present in a proportion of patients with SLE. We have discovered novel mechanisms of disease linked to Sm autoimmunity and HLA, with advanced work on translating this to a novel therapy. Now, we have a need to more deeply explore the associations of anti-Sm positivity with clinical outcomes and biological markers. Using the huge database managed at Monash, linked to thousands of biomarker datapoint, we will deliver this information.
systemic lupus erythematosus, lupus, antibodies, clinical, biomarkers, outcomes
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Medicine - Monash Medical Centre
Masters by research
Top-up scholarship funding available
Monash Health Translation Precinct (Monash Medical Centre)